[ 1 ] Tilg H, Cani PD, Mayer EA. Gut microbiome and liver diseases. Gut 2016;65 (12):2035–44. link1

[ 2 ] Qin N, Yang F, Li A, Prifti E, Chen Y, Shao L, et al. Alterations of the human gut microbiome in liver cirrhosis. Nature 2014;513(7516):59–64. link1

[ 3 ] Acharya C, Sahingur SE, Bajaj JS. Microbiota, cirrhosis, and the emerging oral– gut–liver axis. JCI Insight 2017;2(19):94416. link1

[ 4 ] Jensen A, Groenkjaer LL, Holmstrup P, Vilstrup H, Kilian M. Unique subgingival microbiota associated with periodontitis in cirrhosis patients. Sci Rep 2018;8 (1):10718. link1

[ 5 ] Bajaj JS, Betrapally N, Hylemon PB, Heuman DM, Daita K, White MB, et al. Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy. Hepatology 2015;62(4):1260–71. link1

[ 6 ] Chen YF, Yang F, Lu H, Wang B, Chen Y, Lei D, et al. Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology 2011;54 (2):562–72. link1

[ 7 ] Bik EM, Eckburg PB, Gill SR, Nelson KE, Purdom EA, Francois F, et al. Molecular analysis of the bacterial microbiota in the human stomach. Proc Natl Acad Sci USA 2006;103(3):732–7. link1

[ 8 ] von Rosenvinge EC, Song Y, White JR, Maddox C, Blanchard T, Fricke WF. Immune status, antibiotic medication and pH are associated with changes in the stomach fluid microbiota. ISME J 2013;7(7):1354–66. link1

[ 9 ] Wu WM, Yang YS, Peng LH. Microbiota in the stomach: new insights. J Dig Dis 2014;15(2):54–61. link1

[10] Liu X, Shao L, Liu X, Ji F, Mei Y, Cheng Y, et al. Alterations of gastric mucosal microbiota across different stomach microhabitats in a cohort of 276 patients with gastric cancer. EBioMedicine 2019;40:336–48. link1

[11] Lertpiriyapong K, Whary MT, Muthupalani S, LofgrenJL GER, Feng Y, et al. Gastric colonisation with a restricted commensal microbiota replicates the promotion of neoplastic lesions by diverse intestinal microbiota in the Helicobacter pylori INS-GAS mouse model of gastric carcinogenesis. Gut 2014;63(1):54–63. link1

[12] Maldonado-Contreras A, Goldfarb KC, Godoy-Vitorino F, Karaoz U, Contreras M, Blaser MJ, et al. Structure of the human gastric bacterial community in relation to Helicobacter pylori status. ISME J 2011;5(4):574–9. link1

[13] Aviles-Jimenez F, Vazquez-Jimenez F, Medrano-Guzman R, Mantilla A. Stomach microbiota composition varies between patients with non-atrophic gastritis and patients with intestinal type of gastric cancer. Sci Rep 2014;4:4202. link1

[14] Yu GQ, Gail MH, Shi J, Klepac-Ceraj V, Paster BJ, Dye BA, et al. Association between upper digestive tract microbiota and cancer-predisposing states in the esophagus and stomach. Cancer Epidemiol Biomarkers Prev 2014;23 (5):735–41. link1

[15] Yu G, Torres J, Hu NY, Medrano-Guzman R, Herrera-Goepfert R, Humphrys MS, et al. Molecular characterization of the human stomach microbiota in gastric cancer patients. Front Cell Infect Microbiol 2017;7:302. link1

[16] Kalaitzakis E. Gastrointestinal dysfunction in liver cirrhosis. World J Gastroenterol 2014;20(40):14686–95. link1

[17] Kalaitzakis E, Sadik R, Holst JJ, Ohman L, Björnsson ES. Gut transit is associated with gastrointestinal symptoms and gut hormone profile in patients with cirrhosis. Clin Gastroenterol Hepatol 2009;7(3):346–52. link1

[18] Kalaitzakis E, Simren M, Abrahamsson H, Björnsson ES. Role of gastric sensorimotor dysfunction in gastrointestinal symptoms and energy intake in liver cirrhosis. Scand J Gastroenterol 2007;42(2):237–46. link1

[19] Verne GN, Soldevia-Pico C, Robinson ME, McRae Spicer K, Reuben A. Autonomic dysfunction and gastroparesis in cirrhosis. J Clin Gastroenterol 2004;38(1):72–6. link1

[20] Norman K, Pirlich M. Gastrointestinal tract in liver disease: which organ is sick? Curr Opin Clin Nutr Metab Care 2008;11(5):613–9. link1

[21] Karki L, Gorkhaly MP, Karki BB. Study of upper gastrointestinal tract endoscopic findings in portal hypertension. JNMA J Nepal Med Assoc 2013;52(190):337–42. link1

[22] Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60(8):646–9. link1

[23] Rentz AM, Kahrilas PJ, Stanghellini V, Tack J, Talley N, de la Loge C, et al. Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders. Qual Life Res 2004;13(10):1737–49. link1

[24] Chen W, Liu F, Ling Z, Tong X, Xiang C. Human intestinal lumen and mucosaassociated microbiota in patients with colorectal cancer. PLoS One 2012;7(6): e39743. link1

[25] Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 2010;7(5):335–6. link1

[26] Edgar RC. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 2010;26(19):2460–1. link1

[27] McMurdie PJ, Holmes S. Phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS One 2013;8(4):e61217. link1

[28] Langille MG, Zaneveld J, Caporaso JG, McDonald D, Knights D, Reyes JA, et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol 2013;31(9):814–21. link1

[29] Jalan R, Hayes PC. UK guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut 2000;46(Suppl 3–4):III1–15.

[30] Chang SS, Hu HY. Helicobacter pylori is not the predominant etiology for liver cirrhosis patients with peptic ulcer disease. Eur J Gastroenterol Hepatol 2013;25(2):159–65. link1

[31] Kirchner GI, Beil W, Bleck JS, Manns MP, Wagner S. Prevalence of Helicobacter pylori and occurrence of gastroduodenal lesions in patients with liver cirrhosis. Int J Clin Exp Med 2011;4(1):26–31. link1

[32] Nam YJ, Kim SJ, Shin WC, Lee JH, Choi WC, Kim KY, et al. Gastric pH and Helicobacter pylori infection in patients with liver cirrhosis. Korean J Hepatol 2004;10(3):216–22. link1

[33] Ibrisim D, Cevikbas U, Akyüz F, Poturoglu S, Ahishali E, Gulluoglu M, et al. Intestinal metaplasia in portal hypertensive gastropathy: a frequent pathology. Eur J Gastroenterol Hepatol 2008;20(9):874–80. link1

[34] Karnes WE, Samloff IM, Siurala M, Kekki M, Sipponen P, Kim SWR, et al. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology 1991;101(1): 167–74. link1

[35] Garcia-Mazcorro JF, Suchodolski JS, Jones KR, Clark-Price SC, Dowd SE, Minamoto Y, et al. Effect of the proton pump inhibitor omeprazole on the gastrointestinal bacterial microbiota of healthy dogs. FEMS Microbiol Ecol 2012;80(3):624–36. link1

[36] Cover TL, Blaser MJ. Helicobacter pylori in health and disease. Gastroenterology 2009;136(6):1863–73. link1

[37] Hasni SA. Role of Helicobacter pylori infection in autoimmune diseases. Curr Opin Rheumatol 2012;24(4):429–34. link1

[38] Nardone G, Compare D. The human gastric microbiota: is it time to rethink the pathogenesis of stomach diseases? United Eur Gastroenterol J 2015;3 (3):255–60. link1

[39] Fritz E, Hammer J. Gastrointestinal symptoms in patients with liver cirrhosis are linked to impaired quality of life and psychological distress. Eur J Gastroenterol Hepatol 2009;21(4):460–5. link1

[40] Han HS, Lee SY, Oh SY, Moon HW, Cho H, Kim JH. Correlations of the gastric and duodenal microbiota with histological, endoscopic, and symptomatic gastritis. J Clin Med 2019;8(3):312. link1

[41] Fukui A, Takagi T, Naito Y, Inoue R, Kashiwagi S, Mizushima K, et al. Higher levels of streptococcus in upper gastrointestinal mucosa associated with symptoms in patients with functional dyspepsia. Digestion 2020;101 (1):38–45. link1

[42] Budzynski J, Klopocka M. Brain-gut axis in the pathogenesis of Helicobacter pylori infection. World J Gastroenterol 2014;20(18):5212–25. link1

[43] Rhee SH, Pothoulakis C, Mayer EA. Principles and clinical implications of the brain–gut–enteric microbiota axis. Nat Rev Gastroenterol Hepatol 2009;6 (5):306–14. link1

[44] Simren M, Barbara G, Flint HJ, Spiegel B, Spiller R, Vanner S, et al. Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut 2013;62(1):159–76. link1

[45] Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 2012;13(10):701–12. link1

[46] De Franchis R, Fac BV. Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension. J Hepatology 2015;63(3):743–52. link1

[47] Vadera S, Yang C, Morgan MY, Gluud L. Band ligation versus no intervention for primary prevention of upper gastrointestinal bleeding in adults with cirrhosis and oesophageal varices. Cochrane Database Syst Rev 2019;(6):CD012673.

[48] Narawane NM, Bhatia S, Sheth M, Dherai AJ, Abraham P, Paranjape AY, et al. Early changes in esophageal motility after endoscopic variceal sclerotherapy or ligation. Indian J Gastroenterol 1999;18(1):11–4. link1

[49] Fernandez J, Navasa M, Gómez J, Colmenero J, Vila J, Arroyo V, et al. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 2002;35(1):140–8. link1

[50] Maimone S, Saffioti F, Filomia R, Filomia G, Saitta C, Pallio S, et al. Elective endoscopic variceal ligation is not a risk factor for bacterial infection in patients with liver cirrhosis. Dig Liver Dis 2018;50(4):366–9. link1

[51] Koropatkin NM, Cameron EA, Martens EC. How glycan metabolism shapes the human gut microbiota. Nat Rev Microbiol 2012;10(5):323–35. link1

[52] Kaczanowska M, Ryden-Aulin M. Ribosome biogenesis and the translation process in Escherichia coli. Microbiol Mol Biol Rev 2007;71(3):477–94. link1

[53] Epelde L, Lanzén A, Blanco F, Urich T, Garbisu C. Adaptation of soil microbial community structure and function to chronic metal contamination at an abandoned Pb–Zn mine. FEMS Microbiol Ecol 2015;91(1):1–11. link1